Area lab company buys British firm in $390 million deal

Fort Myers-based NeoGenomics made its first investment into the firm in May 2020.

By Business Observer Staff
| 10:20 a.m. May 7, 2021
| 0 Free Articles Remaining!

Charlotte–Lee–Collier

FORT MYERS — Leading cancer-focused genetic testing services firm NeoGenomics has acquired a British-based liquid biopsy firm, Inivata.

Fort Myers-based NeoGenomics invested $25 million into Cambridge-based Inivata in May 2020, according to a statement. At the time of the investment, NeoGenomics was granted a fixed price option to purchase the remainder of Inivata for $390 million prior to Dec. 31, 2021.